with range rdfs:Resource

Subject	Object
?:1-methylxanthine_has_metabolite_1-methyluric-acid	?:evidence_1016
?:14-hydroxyclarithromycin_maximum_concentration_continuous_value	?:evidence_1009
?:14-hydroxyclarithromycin_maximum_concentration_continuous_value	?:evidence_1478
?:14-hydroxyclarithromycin_maximum_concentration_continuous_value	?:evidence_1633
?:14-hydroxyclarithromycin_maximum_concentration_continuous_value	?:evidence_1768
?:7-ethoxyresorufin_in_vitro_probe_substrate_of_enzyme_cyp1a2	?:evidence_1120
?:7-hydroxyperphenazine_maximum_concentration_continuous_value	?:evidence_1385
?:9-hydroxyrisperidone_inhibition_constant_cyp2d6	?:evidence_1037
?:9-hydroxyrisperidone_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1081
?:N-demethyldesacetyl-diltiazem_primary_total_clearance_enzyme_cyp2d6	?:evidence_1074
?:N-demethyldesacetyl-diltiazem_substrate_of_cyp2d6	?:evidence_1470
?:N-desalkylquetiapine_does_not_inhibit_cyp1a2	?:evidence_1359
?:N-desalkylquetiapine_does_not_inhibit_cyp2c19	?:evidence_1895
?:N-desalkylquetiapine_does_not_inhibit_cyp2c9	?:evidence_1315
?:N-desalkylquetiapine_does_not_inhibit_cyp2d6	?:evidence_1221
?:N-desalkylquetiapine_does_not_inhibit_cyp3a4	?:evidence_1002
?:N-desalkylquetiapine_substrate_of_cyp3a4	?:evidence_1071
?:O-desmethylvenlafaxine_maximum_concentration_continuous_value	?:evidence_1356
?:O-desmethylvenlafaxine_maximum_concentration_continuous_value	?:evidence_1668
?:O-desmethylvenlafaxine_maximum_concentration_continuous_value	?:evidence_1833
?:R-citalopram_does_not_inhibit_cyp1a2	?:evidence_1440
?:R-citalopram_does_not_inhibit_cyp2c19	?:evidence_1641
?:R-citalopram_does_not_inhibit_cyp2c9	?:evidence_1013
?:R-citalopram_does_not_inhibit_cyp2d6	?:evidence_1317
?:R-citalopram_substrate_of_cyp2c19	?:evidence_1196
?:R-citalopram_substrate_of_cyp2d6	?:evidence_1949
?:R-citalopram_substrate_of_cyp3a4	?:evidence_1855
?:R-demethylcitalopram_does_not_inhibit_cyp1a2	?:evidence_1278
?:R-demethylcitalopram_does_not_inhibit_cyp2c19	?:evidence_1302
?:R-demethylcitalopram_does_not_inhibit_cyp2c9	?:evidence_1664
?:R-demethylcitalopram_maximum_concentration_continuous_value	?:evidence_1663
?:R-demethylcitalopram_substrate_of_cyp2d6	?:evidence_1640
?:R-didemethylcitalopram_does_not_inhibit_cyp1a2	?:evidence_1190
?:R-didemethylcitalopram_does_not_inhibit_cyp2d6	?:evidence_1106
?:R-didemethylcitalopram_maximum_concentration_continuous_value	?:evidence_1961
?:S-demethylcitalopram_does_not_inhibit_cyp1a2	?:evidence_1983
?:S-demethylcitalopram_does_not_inhibit_cyp2c19	?:evidence_1638
?:S-demethylcitalopram_does_not_inhibit_cyp2c9	?:evidence_1942
?:S-demethylcitalopram_maximum_concentration_continuous_value	?:evidence_1596
?:S-demethylcitalopram_substrate_of_cyp2d6	?:evidence_1602
?:S-didemethylcitalopram_does_not_inhibit_cyp1a2	?:evidence_1103
?:S-didemethylcitalopram_does_not_inhibit_cyp2d6	?:evidence_1161
?:S-didemethylcitalopram_maximum_concentration_continuous_value	?:evidence_1847
?:S-mephenytoin_in_vitro_probe_substrate_of_enzyme_cyp2c19	?:evidence_1416
?:S-warfarin_in_vitro_probe_substrate_of_enzyme_cyp2c9	?:evidence_1962
?:S-warfarin_primary_total_clearance_enzyme_cyp2c9	?:evidence_1656
?:alpha-naphthoflavone_in_vitro_selective_inhibitor_of_enzyme_cyp1a2	?:evidence_1198
?:alprazolam_bioavailability_continuous_value	?:evidence_1744
?:alprazolam_bioavailability_continuous_value	?:evidence_1758
?:alprazolam_has_metabolite_4-hydroxyalprazolam	?:evidence_1159
?:alprazolam_has_metabolite_4-hydroxyalprazolam	?:evidence_1485
?:alprazolam_has_metabolite_alpha-hydroxyalprazolam	?:evidence_1093
?:alprazolam_has_metabolite_alpha-hydroxyalprazolam	?:evidence_1206
?:alprazolam_is_not_substrate_of_cyp1a2	?:evidence_1506
?:alprazolam_maximum_concentration_continuous_value	?:evidence_1673
?:alprazolam_maximum_concentration_continuous_value	?:evidence_1705
?:alprazolam_primary_metabolic_clearance_enzyme_cyp3a4	?:evidence_1679
?:alprazolam_primary_metabolic_clearance_enzyme_cyp3a4	?:evidence_1830
?:alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1322
?:alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1494
?:alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1858
?:alprazolam_substrate_of_cyp3a4	?:evidence_1341
?:alprazolam_substrate_of_cyp3a4	?:evidence_1371
?:alprazolam_substrate_of_cyp3a4	?:evidence_1559
?:alprazolam_substrate_of_cyp3a5	?:evidence_1169
?:alprazolam_substrate_of_cyp3a5	?:evidence_1774
?:amiodarone_inhibits_cyp1a2	?:evidence_1242
?:amiodarone_inhibits_cyp2c9	?:evidence_1262
?:amiodarone_inhibits_cyp2c9	?:evidence_1706
?:amiodarone_inhibits_cyp2d6	?:evidence_1639
?:amiodarone_inhibits_cyp2d6	?:evidence_1985
?:amiodarone_inhibits_cyp3a4	?:evidence_1447
?:aripiprazole_bioavailability_continuous_value	?:evidence_1572
?:aripiprazole_does_not_inhibit_cyp1a2	?:evidence_1249
?:aripiprazole_does_not_inhibit_cyp2c19	?:evidence_1033
?:aripiprazole_does_not_inhibit_cyp2c9	?:evidence_1444
?:aripiprazole_does_not_inhibit_cyp2d6	?:evidence_1939
?:aripiprazole_does_not_inhibit_cyp3a4	?:evidence_1750
?:aripiprazole_has_metabolite_dehydro-aripiprazole	?:evidence_1963
?:aripiprazole_increases_auc_escitalopram	?:evidence_1233
?:aripiprazole_increases_auc_venlafaxine	?:evidence_1651
?:aripiprazole_is_not_substrate_of_cyp1a1	?:evidence_1052
?:aripiprazole_is_not_substrate_of_cyp1a2	?:evidence_1112
?:aripiprazole_is_not_substrate_of_cyp2a6	?:evidence_1574
?:aripiprazole_is_not_substrate_of_cyp2b6	?:evidence_1508
?:aripiprazole_is_not_substrate_of_cyp2c19	?:evidence_1835
?:aripiprazole_is_not_substrate_of_cyp2c8	?:evidence_1655
?:aripiprazole_is_not_substrate_of_cyp2c9	?:evidence_1910
?:aripiprazole_is_not_substrate_of_cyp2e1	?:evidence_1460
?:aripiprazole_maximum_concentration_continuous_value	?:evidence_1070
?:aripiprazole_maximum_concentration_continuous_value	?:evidence_1647
?:aripiprazole_maximum_concentration_continuous_value	?:evidence_1760
?:aripiprazole_maximum_concentration_continuous_value	?:evidence_1839
?:aripiprazole_maximum_concentration_continuous_value	?:evidence_1889
?:aripiprazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1015
?:aripiprazole_substrate_of_cyp2d6	?:evidence_1674
?:aripiprazole_substrate_of_cyp3a4	?:evidence_1439
?:aripiprazole_substrate_of_cyp3a4	?:evidence_1800
?:asenapine_is_not_substrate_of_cyp2d6	?:evidence_1425
?:asenapine_maximum_concentration_continuous_value	?:evidence_1730
?:asenapine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1148
?:atazanavir_does_not_inhibit_cyp1a2	?:evidence_1816
?:atazanavir_does_not_inhibit_cyp2a6	?:evidence_1313
?:atazanavir_does_not_inhibit_cyp2b6	?:evidence_1470
?:atazanavir_does_not_inhibit_cyp2c19	?:evidence_1475
?:atazanavir_does_not_inhibit_cyp2c9	?:evidence_1581
?:atazanavir_does_not_inhibit_cyp2d6	?:evidence_1825
?:atazanavir_does_not_inhibit_cyp2e1	?:evidence_1642
?:atazanavir_inhibits_cyp3a4	?:evidence_1699
?:atazanavir_inhibits_cyp3a4	?:evidence_1729
?:atazanavir_inhibits_cyp3a5	?:evidence_1591
?:atazanavir_inhibits_cyp3a5	?:evidence_1835
?:atomoxetine_bioavailability_continuous_value	?:evidence_1825
?:atomoxetine_does_not_inhibit_cyp1a2	?:evidence_1750
?:atomoxetine_does_not_inhibit_cyp2c9	?:evidence_1281
?:atomoxetine_does_not_inhibit_cyp2d6	?:evidence_1126
?:atomoxetine_does_not_inhibit_cyp2d6	?:evidence_1616
?:atomoxetine_has_metabolite_4-hydroxyatomoxetine	?:evidence_1215
?:atomoxetine_has_metabolite_N-desmethylatomoxetine	?:evidence_1145
?:atomoxetine_primary_total_clearance_enzyme_cyp2d6	?:evidence_1486
?:atomoxetine_primary_total_clearance_enzyme_cyp2d6	?:evidence_1940
?:atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1915
?:atorvastatin_bioavailability_continuous_value	?:evidence_1704
?:atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin	?:evidence_1200
?:atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin	?:evidence_1265
?:atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin	?:evidence_1444
?:atorvastatin_has_metabolite_para-hydroxy-atorvastatin	?:evidence_1026
?:atorvastatin_has_metabolite_para-hydroxy-atorvastatin	?:evidence_1259
?:atorvastatin_has_metabolite_para-hydroxy-atorvastatin	?:evidence_1266
?:atorvastatin_inhibition_constant_cyp2c8	?:evidence_1911
?:atorvastatin_inhibits_cyp3a4	?:evidence_1034
?:atorvastatin_is_not_substrate_of_cyp1a1	?:evidence_1534
?:atorvastatin_is_not_substrate_of_cyp2b6	?:evidence_1958
?:atorvastatin_is_not_substrate_of_cyp2c19	?:evidence_1037
?:atorvastatin_is_not_substrate_of_cyp2c9	?:evidence_1424
?:atorvastatin_is_not_substrate_of_cyp2d6	?:evidence_1728
?:atorvastatin_is_not_substrate_of_cyp2e1	?:evidence_1818
?:atorvastatin_maximum_concentration_continuous_value	?:evidence_1094
?:atorvastatin_maximum_concentration_continuous_value	?:evidence_1591
?:atorvastatin_maximum_concentration_continuous_value	?:evidence_1912
?:atorvastatin_maximum_concentration_continuous_value	?:evidence_1966
?:atorvastatin_primary_total_clearance_enzyme_cyp3a4	?:evidence_1230
?:atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1214
?:atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1647
?:atorvastatin_substrate_of_cyp3a4	?:evidence_1169
?:atorvastatin_substrate_of_cyp3a4	?:evidence_1246
?:atorvastatin_substrate_of_cyp3a4	?:evidence_1636
?:atorvastatin_substrate_of_cyp3a5	?:evidence_1435
?:atorvastatin_substrate_of_cyp3a5	?:evidence_1756
?:beta-hydroxy-lovastatin_has_metabolite_6'-exomethylene-lovastatin	?:evidence_1065
?:beta-hydroxy-lovastatin_has_metabolite_6'beta-hydroxy-lovastatin	?:evidence_1823
?:beta-hydroxy-lovastatin_inhibition_constant_cyp2c8	?:evidence_1068
?:beta-hydroxy-lovastatin_maximum_concentration_continuous_value	?:evidence_1409
?:beta-hydroxy-lovastatin_primary_total_clearance_enzyme_cyp3a4	?:evidence_1342
?:beta-hydroxy-lovastatin_substrate_of_cyp3a4	?:evidence_1422
?:beta-hydroxy-lovastatin_substrate_of_cyp3a4	?:evidence_1707
?:beta-hydroxy-simvastatin_does_not_inhibit_cyp3a4	?:evidence_1457
?:beta-hydroxy-simvastatin_has_metabolite_6'-exomethylene-simvastatin	?:evidence_1615
?:beta-hydroxy-simvastatin_has_metabolite_6'-hydroxy-simvastatin	?:evidence_1822
?:beta-hydroxy-simvastatin_has_metabolite_6'-hydroxymethyl-simvastatin	?:evidence_1746
?:beta-hydroxy-simvastatin_inhibition_constant_cyp2c8	?:evidence_1967
?:beta-hydroxy-simvastatin_primary_total_clearance_enzyme_cyp3a4	?:evidence_1010
?:beta-hydroxy-simvastatin_substrate_of_cyp3a4	?:evidence_1228
?:beta-hydroxy-simvastatin_substrate_of_cyp3a4	?:evidence_1272
?:bufuralol_in_vitro_probe_substrate_of_enzyme_cyp2d6	?:evidence_1698
?:bupropion_has_metabolite_erythrohydrobupropion	?:evidence_1128
?:bupropion_has_metabolite_hydroxybupropion	?:evidence_1872
?:bupropion_has_metabolite_threohydrobupropion	?:evidence_1383
?:bupropion_increases_auc_desipramine	?:evidence_1411
?:bupropion_inhibits_cyp2d6	?:evidence_1384
?:bupropion_inhibits_cyp2d6	?:evidence_1570
?:bupropion_maximum_concentration_continuous_value	?:evidence_1203
?:bupropion_maximum_concentration_continuous_value	?:evidence_1244
?:bupropion_maximum_concentration_continuous_value	?:evidence_1367
?:bupropion_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1010
?:bupropion_substrate_of_cyp2b6	?:evidence_1064
?:caffeine_primary_total_clearance_enzyme_cyp1a2	?:evidence_1761
?:celecoxib_does_not_inhibit_cyp2c19	?:evidence_1870
?:celecoxib_does_not_inhibit_cyp2c9	?:evidence_1145
?:celecoxib_does_not_inhibit_cyp3a4	?:evidence_1425
?:celecoxib_inhibits_cyp2d6	?:evidence_1240
?:celecoxib_inhibits_cyp2d6	?:evidence_1621
?:celecoxib_maximum_concentration_continuous_value	?:evidence_1963
?:celecoxib_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1201
?:celecoxib_substrate_of_cyp2c9	?:evidence_1852
?:chlorpromazine_bioavailability_continuous_value	?:evidence_1268
?:chlorpromazine_does_not_inhibit_cyp2c19	?:evidence_1685
?:chlorpromazine_maximum_concentration_continuous_value	?:evidence_1183
?:chlorpromazine_maximum_concentration_continuous_value	?:evidence_1911
?:chlorpromazine_maximum_concentration_continuous_value	?:evidence_1956
?:chlorzoxazone_in_vitro_probe_substrate_of_enzyme_cyp2e1	?:evidence_1923
?:cimetidine_increases_auc_amitriptyline	?:evidence_1710
?:cimetidine_increases_auc_amitriptyline	?:evidence_1833
?:cimetidine_increases_auc_citalopram	?:evidence_1490
?:cimetidine_increases_auc_doxepin	?:evidence_1784
?:cimetidine_increases_auc_erythrohydrobupropion	?:evidence_1099
?:cimetidine_increases_auc_escitalopram	?:evidence_1695
?:cimetidine_increases_auc_imipramine	?:evidence_1308
?:cimetidine_increases_auc_imipramine	?:evidence_1742
?:cimetidine_increases_auc_imipramine	?:evidence_1765
?:cimetidine_increases_auc_mirtazapine	?:evidence_1565
?:cimetidine_increases_auc_paroxetine	?:evidence_1685
?:cimetidine_increases_auc_quetiapine	?:evidence_1222
?:cimetidine_increases_auc_sertraline	?:evidence_1553
?:cimetidine_increases_auc_theophylline	?:evidence_1144
?:cimetidine_increases_auc_threohydrobupropion	?:evidence_1058
?:cimetidine_increases_auc_venlafaxine	?:evidence_1214
?:cimetidine_increases_auc_venlafaxine	?:evidence_1871
?:cimetidine_increases_auc_ziprasidone	?:evidence_1770
?:cimetidine_inhibits_cyp1a2	?:evidence_1836
?:cimetidine_inhibits_cyp3a4	?:evidence_1029
?:cimetidine_inhibits_cyp3a5	?:evidence_1633
?:cinacalcet_does_not_inhibit_cyp1a2	?:evidence_1815
?:cinacalcet_does_not_inhibit_cyp2c19	?:evidence_1633
?:cinacalcet_does_not_inhibit_cyp2c9	?:evidence_1817
?:cinacalcet_does_not_inhibit_cyp3a4	?:evidence_1556
?:cinacalcet_does_not_inhibit_cyp3a4	?:evidence_1877
?:cinacalcet_does_not_inhibit_cyp3a5	?:evidence_1787
?:cinacalcet_has_metabolite_hydrocinnamic-acid	?:evidence_1410
?:cinacalcet_has_metabolite_hydroxy-hydrocinnamic-acid	?:evidence_1323
?:cinacalcet_inhibits_cyp2d6	?:evidence_1210
?:cinacalcet_inhibits_cyp2d6	?:evidence_1548
?:cinacalcet_inhibits_cyp2d6	?:evidence_1974
?:cinacalcet_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1420
?:cinacalcet_substrate_of_cyp1a2	?:evidence_1016
?:cinacalcet_substrate_of_cyp2d6	?:evidence_1689
?:cinacalcet_substrate_of_cyp3a4	?:evidence_1812
?:cinacalcet_substrate_of_cyp3a4	?:evidence_1926
?:ciprofloxacin_inhibits_cyp1a2	?:evidence_1152
?:ciprofloxacin_inhibits_cyp1a2	?:evidence_1958
?:citalopram_bioavailability_continuous_value	?:evidence_1572
?:citalopram_does_not_inhibit_cyp2c9	?:evidence_1697
?:citalopram_does_not_inhibit_cyp2c9	?:evidence_1804
?:citalopram_does_not_inhibit_cyp2e1	?:evidence_1259
?:citalopram_does_not_inhibit_cyp3a4	?:evidence_1292
?:citalopram_does_not_inhibit_cyp3a4	?:evidence_1836
?:citalopram_does_not_inhibit_cyp3a4	?:evidence_1961
?:citalopram_has_metabolite_demethylcitalopram	?:evidence_1867
?:citalopram_has_metabolite_didemethylcitalopram	?:evidence_1427
?:citalopram_increases_auc_desipramine	?:evidence_1950
?:citalopram_is_not_substrate_of_cyp3a4	?:evidence_1059
?:citalopram_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1897
?:citalopram_substrate_of_cyp2c19	?:evidence_1832
?:citalopram_substrate_of_cyp3a4	?:evidence_1802
?:clarithromycin_bioavailability_continuous_value	?:evidence_1944
?:clarithromycin_fraction_absorbed_continuous_value	?:evidence_1864
?:clarithromycin_has_metabolite_14-hydroxyclarithromycin	?:evidence_1015
?:clarithromycin_has_metabolite_14-hydroxyclarithromycin	?:evidence_1673
?:clarithromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1153
?:clarithromycin_increases_auc_atorvastatin	?:evidence_1730
?:clarithromycin_increases_auc_atorvastatin	?:evidence_1972
?:clarithromycin_increases_auc_lansoprazole	?:evidence_1072
?:clarithromycin_increases_auc_midazolam	?:evidence_1195
?:clarithromycin_increases_auc_midazolam	?:evidence_1322
?:clarithromycin_increases_auc_pravastatin	?:evidence_1057
?:clarithromycin_increases_auc_trazodone	?:evidence_1736
?:clarithromycin_increases_auc_triazolam	?:evidence_1854
?:clarithromycin_inhibition_constant_cyp3a4	?:evidence_1426
?:clarithromycin_inhibition_constant_cyp3a4	?:evidence_1525
?:clarithromycin_inhibition_constant_cyp3a4	?:evidence_1943
?:clarithromycin_inhibits_cyp3a4	?:evidence_1466
?:clarithromycin_inhibits_cyp3a4	?:evidence_1479
?:clarithromycin_inhibits_cyp3a4	?:evidence_1649
?:clarithromycin_inhibits_cyp3a5	?:evidence_1347
?:clarithromycin_inhibits_cyp3a5	?:evidence_1697
?:clarithromycin_is_not_substrate_of_cyp1a2	?:evidence_1219
?:clarithromycin_is_not_substrate_of_cyp2c9	?:evidence_1293
?:clarithromycin_is_not_substrate_of_cyp2d6	?:evidence_1243
?:clarithromycin_maximum_concentration_continuous_value	?:evidence_1308
?:clarithromycin_maximum_concentration_continuous_value	?:evidence_1374
?:clarithromycin_maximum_concentration_continuous_value	?:evidence_1498
?:clarithromycin_maximum_concentration_continuous_value	?:evidence_1935
?:clarithromycin_substrate_of_cyp3a4	?:evidence_1367
?:clarithromycin_substrate_of_cyp3a4	?:evidence_1804
?:clopidogrel_increases_auc_bupropion	?:evidence_1051
?:clopidogrel_inhibition_constant_cyp2b6	?:evidence_1165
?:clozapine-N-oxide_is_not_substrate_of_cyp2d6	?:evidence_1565
?:clozapine_does_not_inhibit_cyp2c19	?:evidence_1577
?:clozapine_has_metabolite_7-hydroxyclozapine	?:evidence_1091
?:clozapine_has_metabolite_clozapine-N-oxide	?:evidence_1465
?:clozapine_has_metabolite_desmethylclozapine	?:evidence_1510
?:clozapine_inhibition_constant_cyp2c19	?:evidence_1310
?:clozapine_inhibition_constant_cyp2c9	?:evidence_1828
?:clozapine_inhibition_constant_cyp2d6	?:evidence_1713
?:clozapine_inhibition_constant_cyp3a4	?:evidence_1792
?:clozapine_maximum_concentration_continuous_value	?:evidence_1111
?:clozapine_maximum_concentration_continuous_value	?:evidence_1244
?:clozapine_maximum_concentration_continuous_value	?:evidence_1253
?:clozapine_maximum_concentration_continuous_value	?:evidence_1616
?:clozapine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1978
?:clozapine_substrate_of_cyp1a2	?:evidence_1068
?:clozapine_substrate_of_cyp1a2	?:evidence_1502
?:clozapine_substrate_of_cyp2d6	?:evidence_1939
?:clozapine_substrate_of_cyp2d6	?:evidence_1970
?:clozapine_substrate_of_cyp3a4	?:evidence_1019
?:clozapine_substrate_of_cyp3a4	?:evidence_1299
?:coumarin_in_vitro_probe_substrate_of_enzyme_cyp2a6	?:evidence_1503
?:cyp1a2_controls_formation_of_3-methylxanthine	?:evidence_1448
?:cyp1a2_controls_formation_of_N-dealkylperphenazine	?:evidence_1691
?:cyp1a2_controls_formation_of_N-dealkylperphenazine	?:evidence_1785
?:cyp2b6_controls_formation_of_hydroxybupropion	?:evidence_1089
?:cyp2b6_controls_formation_of_hydroxybupropion	?:evidence_1206
?:cyp2c19_controls_formation_of_N-dealkylperphenazine	?:evidence_1893
?:cyp2c19_controls_formation_of_N-desmethylatomoxetine	?:evidence_1859
?:cyp2c19_controls_formation_of_N-desmethylsertraline	?:evidence_1845
?:cyp2c8_controls_formation_of_6alpha-hydroxy-paclitaxel	?:evidence_1368
?:cyp2c8_controls_formation_of_N-dealkylperphenazine	?:evidence_1179
?:cyp2c9_controls_formation_of_N-dealkylperphenazine	?:evidence_1038
?:cyp2c9_controls_formation_of_N-desmethylrosuvastatin	?:evidence_1478
?:cyp2d6_controls_formation_of_4-hydroxyatomoxetine	?:evidence_1752
?:cyp2d6_controls_formation_of_4-hydroxydebrisoquine	?:evidence_1182
?:cyp2d6_controls_formation_of_9-hydroxyrisperidone	?:evidence_1958
?:cyp2d6_controls_formation_of_N-dealkylperphenazine	?:evidence_1413
?:cyp2d6_controls_formation_of_N-dealkylperphenazine	?:evidence_1827
?:cyp2d6_controls_formation_of_O-desmethylvenlafaxine	?:evidence_1006
?:cyp2d6_controls_formation_of_O-desmethylvenlafaxine	?:evidence_1026
?:cyp2d6_controls_formation_of_O-desmethylvenlafaxine	?:evidence_1982
?:cyp2e1_controls_formation_of_1,3-dimethyluric-acid	?:evidence_1472
?:cyp3a4_controls_formation_of_1'-hydroxymidazolam	?:evidence_1885
?:cyp3a4_controls_formation_of_1,3-dimethyluric-acid	?:evidence_1412
?:cyp3a4_controls_formation_of_14-hydroxyclarithromycin	?:evidence_1419
?:cyp3a4_controls_formation_of_14-hydroxyclarithromycin	?:evidence_1809
?:cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine	?:evidence_1081
?:cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine	?:evidence_1164
?:cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine	?:evidence_1768
?:cyp3a4_controls_formation_of_4-hydroxyalprazolam	?:evidence_1334
?:cyp3a4_controls_formation_of_4-hydroxymidazolam	?:evidence_1663
?:cyp3a4_controls_formation_of_6'beta-hydroxy-lovastatin	?:evidence_1734
?:cyp3a4_controls_formation_of_N-dealkylperphenazine	?:evidence_1066
?:cyp3a4_controls_formation_of_N-dealkylperphenazine	?:evidence_1886
?:cyp3a4_controls_formation_of_N-desmethyltamoxifen	?:evidence_1924
?:cyp3a4_controls_formation_of_N-desmethylvenlafaxine	?:evidence_1663
?:cyp3a4_controls_formation_of_N-desmethylvenlafaxine	?:evidence_1891
?:cyp3a4_controls_formation_of_alpha-hydroxyalprazolam	?:evidence_1606
?:cyp3a4_controls_formation_of_desmethylcitalopram	?:evidence_1446
?:cyp3a4_controls_formation_of_ortho-hydroxy-atorvastatin	?:evidence_1904
?:cyp3a4_controls_formation_of_para-hydroxy-atorvastatin	?:evidence_1198
?:cyp3a4_controls_formation_of_ziprasidone-sulphoxide	?:evidence_1004
?:cyp3a5_controls_formation_of_1'-hydroxymidazolam	?:evidence_1203
?:cyp3a5_controls_formation_of_4-hydroxyalprazolam	?:evidence_1982
?:cyp3a5_controls_formation_of_4-hydroxymidazolam	?:evidence_1620
?:cyp3a5_controls_formation_of_alpha-hydroxyalprazolam	?:evidence_1643
?:cyp3a5_controls_formation_of_ortho-hydroxy-atorvastatin	?:evidence_1106
?:cyp3a5_controls_formation_of_para-hydroxy-atorvastatin	?:evidence_1592
?:debrisoquine_in_vitro_probe_substrate_of_enzyme_cyp2d6	?:evidence_1185
?:dehydro-aripiprazole_does_not_inhibit_cyp1a2	?:evidence_1912
?:dehydro-aripiprazole_substrate_of_cyp3a4	?:evidence_1011
?:dehydro-aripiprazole_substrate_of_cyp3a4	?:evidence_1208
?:demethylcitalopram_does_not_inhibit_cyp3a4	?:evidence_1928
?:demethylcitalopram_is_not_substrate_of_cyp2c19	?:evidence_1257
?:demethylcitalopram_is_not_substrate_of_cyp3a4	?:evidence_1874
?:desacetyldiltiazem_primary_total_clearance_enzyme_cyp2d6	?:evidence_1911
?:desacetyldiltiazem_substrate_of_cyp2d6	?:evidence_1627
?:desglymidodrine_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1877
?:desipramine_primary_total_clearance_enzyme_cyp2d6	?:evidence_1914
?:desvenlafaxine_increases_auc_desipramine	?:evidence_1508
?:desvenlafaxine_increases_auc_desipramine	?:evidence_1694
?:desvenlafaxine_is_not_substrate_of_cyp2d6	?:evidence_1563
?:dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d6	?:evidence_1263
?:dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d6	?:evidence_1949
?:dextromethorphan_primary_total_clearance_enzyme_cyp2d6	?:evidence_1239
?:diltiazem_bioavailability_continuous_value	?:evidence_1020
?:diltiazem_bioavailability_continuous_value	?:evidence_1120
?:diltiazem_bioavailability_continuous_value	?:evidence_1151
?:diltiazem_bioavailability_continuous_value	?:evidence_1169
?:diltiazem_has_metabolite_N-demethyldesacetyl-diltiazem	?:evidence_1529
?:diltiazem_has_metabolite_N-demethyldiltiazem	?:evidence_1822
?:diltiazem_has_metabolite_desacetyldiltiazem	?:evidence_1760
?:diltiazem_increases_auc_beta-hydroxy-lovastatin	?:evidence_1027
?:diltiazem_increases_auc_imipramine	?:evidence_1129
?:diltiazem_increases_auc_midazolam	?:evidence_1723
?:diltiazem_increases_auc_simvastatin	?:evidence_1866
?:diltiazem_increases_auc_triazolam	?:evidence_1978
?:diltiazem_inhibition_constant_cyp3a4	?:evidence_1357
?:diltiazem_inhibition_constant_cyp3a4	?:evidence_1741
?:diltiazem_inhibition_constant_cyp3a4	?:evidence_1925
?:diltiazem_inhibits_cyp3a4	?:evidence_1612
?:diltiazem_maximum_concentration_continuous_value	?:evidence_1575
?:diltiazem_maximum_concentration_continuous_value	?:evidence_1873
?:diltiazem_permanently_deactivates_catalytic_function_cyp3a4	?:evidence_1894
?:diltiazem_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1971
?:diltiazem_substrate_of_cyp3a4	?:evidence_1760
?:diltiazem_substrate_of_cyp3a5	?:evidence_1695
?:diphenhydramine_increases_auc_venlafaxine	?:evidence_1866
?:duloxetine_does_not_inhibit_cyp2c19	?:evidence_1984
?:duloxetine_does_not_inhibit_cyp2c9	?:evidence_1319
?:duloxetine_does_not_inhibit_cyp3a4	?:evidence_1344
?:duloxetine_does_not_inhibit_cyp3a5	?:evidence_1884
?:duloxetine_increases_auc_theophylline	?:evidence_1750
?:duloxetine_inhibits_cyp2d6	?:evidence_1109
?:duloxetine_inhibits_cyp2d6	?:evidence_1712
?:duloxetine_inhibits_cyp2d6	?:evidence_1903
?:duloxetine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1093
?:duloxetine_substrate_of_cyp1a2	?:evidence_1562
?:duloxetine_substrate_of_cyp2d6	?:evidence_1125
?:duloxetine_substrate_of_cyp2d6	?:evidence_1550
?:erythrohydrobupropion_maximum_concentration_continuous_value	?:evidence_1116
?:erythromycin_in_vitro_probe_substrate_of_enzyme_cyp3a4	?:evidence_1526
?:erythromycin_increases_auc_alprazolam	?:evidence_1202
?:erythromycin_increases_auc_atorvastatin	?:evidence_1760
?:erythromycin_increases_auc_beta-hydroxy-simvastatin	?:evidence_1091
?:erythromycin_increases_auc_midazolam	?:evidence_1103
?:erythromycin_increases_auc_quetiapine	?:evidence_1437
?:erythromycin_increases_auc_simvastatin	?:evidence_1202
?:erythromycin_increases_auc_triazolam	?:evidence_1902
?:erythromycin_inhibition_constant_cyp3a4	?:evidence_1208
?:erythromycin_inhibition_constant_cyp3a4	?:evidence_1654
?:erythromycin_inhibition_constant_cyp3a4	?:evidence_1811
?:erythromycin_inhibits_cyp3a4	?:evidence_1265
?:erythromycin_inhibits_cyp3a4	?:evidence_1434
?:escitalopram_bioavailability_continuous_value	?:evidence_1340
?:escitalopram_does_not_inhibit_cyp1a2	?:evidence_1888
?:escitalopram_does_not_inhibit_cyp2c19	?:evidence_1802
?:escitalopram_does_not_inhibit_cyp2c19	?:evidence_1852
?:escitalopram_does_not_inhibit_cyp2c9	?:evidence_1297
?:escitalopram_does_not_inhibit_cyp2c9	?:evidence_1566
?:escitalopram_does_not_inhibit_cyp2d6	?:evidence_1036
?:escitalopram_does_not_inhibit_cyp2d6	?:evidence_1049
?:escitalopram_does_not_inhibit_cyp2e1	?:evidence_1770
?:escitalopram_has_metabolite_S-demethylcitalopram	?:evidence_1071
?:escitalopram_has_metabolite_S-didemethylcitalopram	?:evidence_1124
?:escitalopram_inhibits_cyp2d6	?:evidence_1394
?:escitalopram_maximum_concentration_continuous_value	?:evidence_1044
?:escitalopram_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1880
?:escitalopram_substrate_of_cyp2c19	?:evidence_1648
?:escitalopram_substrate_of_cyp2c19	?:evidence_1757
?:escitalopram_substrate_of_cyp2d6	?:evidence_1556
?:escitalopram_substrate_of_cyp3a4	?:evidence_1302
?:eszopiclone_does_not_inhibit_CYP1A2	?:evidence_1679
?:eszopiclone_does_not_inhibit_CYP2A6	?:evidence_1012
?:eszopiclone_does_not_inhibit_CYP2C19	?:evidence_1284
?:eszopiclone_does_not_inhibit_CYP2C9	?:evidence_1612
?:eszopiclone_does_not_inhibit_CYP2D6	?:evidence_1381
?:eszopiclone_does_not_inhibit_CYP2E1	?:evidence_1714
?:eszopiclone_does_not_inhibit_CYP3A4	?:evidence_1014
?:eszopiclone_has_metabolite_S-N-desmethylzopiclone	?:evidence_1144
?:eszopiclone_has_metabolite_S-zopiclone-N-oxide	?:evidence_1090
?:eszopiclone_substrate_of_cyp3a4	?:evidence_1054
?:eszopiclone_substrate_of_cyp3a4	?:evidence_1963
?:fluconazole_bioavailability_continuous_value	?:evidence_1580
?:fluconazole_increases_auc_fluvastatin	?:evidence_1923
?:fluconazole_increases_auc_midazolam	?:evidence_1153
?:fluconazole_increases_auc_midazolam	?:evidence_1244
?:fluconazole_increases_auc_midazolam	?:evidence_1400
?:fluconazole_increases_auc_triazolam	?:evidence_1337
?:fluconazole_inhibition_constant_cyp3a4	?:evidence_1461
?:fluconazole_inhibits_cyp2c9	?:evidence_1381
?:fluconazole_inhibits_cyp2c9	?:evidence_1793
?:fluconazole_inhibits_cyp3a4	?:evidence_1140
?:fluconazole_inhibits_cyp3a4	?:evidence_1484
?:fluconazole_inhibits_cyp3a4	?:evidence_1777
?:fluconazole_inhibits_cyp3a5	?:evidence_1902
?:fluconazole_maximum_concentration_continuous_value	?:evidence_1688
?:fluconazole_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1125
?:fluoxetine_has_metabolite_norfluoxetine	?:evidence_1985
?:fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6	?:evidence_1886
?:fluoxetine_increases_auc_alprazolam	?:evidence_1828
?:fluoxetine_increases_auc_desipramine	?:evidence_1454
?:fluoxetine_increases_auc_desipramine	?:evidence_1856
?:fluoxetine_increases_auc_imipramine	?:evidence_1456
?:fluoxetine_increases_auc_olanzapine	?:evidence_1443
?:fluoxetine_increases_auc_propafenone	?:evidence_1210
?:fluoxetine_inhibition_constant_cyp3a4	?:evidence_1344
?:fluoxetine_inhibits_cyp2d6	?:evidence_1166
?:fluoxetine_inhibits_cyp2d6	?:evidence_1375
?:fluoxetine_inhibits_cyp2d6	?:evidence_1794
?:fluoxetine_maximum_concentration_continuous_value	?:evidence_1041
?:fluoxetine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1147
?:fluoxetine_substrate_of_cyp2d6	?:evidence_1409
?:fluoxetine_substrate_of_cyp2d6	?:evidence_1804
?:fluphenazine_bioavailability_continuous_value	?:evidence_1145
?:fluphenazine_does_not_inhibit_cyp2c19	?:evidence_1269
?:fluphenazine_inhibition_constant_cyp1a2	?:evidence_1935
?:fluphenazine_inhibition_constant_cyp2d6	?:evidence_1529
?:fluphenazine_maximum_concentration_continuous_value	?:evidence_1118
?:fluphenazine_maximum_concentration_continuous_value	?:evidence_1239
?:fluvastatin_bioavailability_continuous_value	?:evidence_1032
?:fluvastatin_inhibition_constant_cyp2c8	?:evidence_1540
?:fluvastatin_maximum_concentration_continuous_value	?:evidence_1074
?:fluvastatin_maximum_concentration_continuous_value	?:evidence_1959
?:fluvastatin_maximum_concentration_continuous_value	?:evidence_1997
?:fluvastatin_primary_total_clearance_enzyme_cyp2c9	?:evidence_1302
?:fluvastatin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1184
?:fluvastatin_substrate_of_cyp2c8	?:evidence_1339
?:fluvastatin_substrate_of_cyp2c9	?:evidence_1253
?:fluvastatin_substrate_of_cyp3a4	?:evidence_1533
?:fluvoxamine_bioavailability_continuous_value	?:evidence_1936
?:fluvoxamine_increases_auc_clozapine	?:evidence_1281
?:fluvoxamine_increases_auc_duloxetine	?:evidence_1148
?:fluvoxamine_increases_auc_duloxetine	?:evidence_1265
?:fluvoxamine_increases_auc_lansoprazole	?:evidence_1902
?:fluvoxamine_increases_auc_lansoprazole	?:evidence_1934
?:fluvoxamine_increases_auc_mexiletine	?:evidence_1909
?:fluvoxamine_increases_auc_omeprazole	?:evidence_1652
?:fluvoxamine_increases_auc_quinidine	?:evidence_1512
?:fluvoxamine_increases_auc_theophylline	?:evidence_1803
?:fluvoxamine_increases_auc_thioridazine	?:evidence_1262
?:fluvoxamine_increases_auc_tolbutamide	?:evidence_1873
?:fluvoxamine_inhibition_constant_cyp1a2	?:evidence_1148
?:fluvoxamine_inhibition_constant_cyp1a2	?:evidence_1951
Skipped 10 rows
?:gemfibrozil_inhibits_cyp2c8	?:evidence_1780
?:haloperidol_does_not_inhibit_cyp2c19	?:evidence_1007
?:haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine	?:evidence_1890
?:haloperidol_has_metabolite_reduced-haloperidol	?:evidence_1028
?:haloperidol_inhibition_constant_cyp2d6	?:evidence_1603
?:haloperidol_substrate_of_cyp3a4	?:evidence_1696
?:hydroxybupropion_maximum_concentration_continuous_value	?:evidence_1873
?:hydroxybupropion_maximum_concentration_continuous_value	?:evidence_1958
?:hydroxybupropion_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1941
?:iloperidone_inhibits_cyp2d6	?:evidence_1671
?:iloperidone_is_not_substrate_of_cyp1a1	?:evidence_1441
?:iloperidone_is_not_substrate_of_cyp1a2	?:evidence_1890
?:iloperidone_is_not_substrate_of_cyp2a6	?:evidence_1022
?:iloperidone_is_not_substrate_of_cyp2b6	?:evidence_1135
?:iloperidone_is_not_substrate_of_cyp2c19	?:evidence_1535
?:iloperidone_is_not_substrate_of_cyp2c8	?:evidence_1381
?:iloperidone_is_not_substrate_of_cyp2c9	?:evidence_1771
?:iloperidone_is_not_substrate_of_cyp2e1	?:evidence_1797
?:iloperidone_substrate_of_cyp2d6	?:evidence_1114
?:iloperidone_substrate_of_cyp2d6	?:evidence_1521
?:iloperidone_substrate_of_cyp3a4	?:evidence_1572
?:indinavir_does_not_inhibit_cyp1a2	?:evidence_1730
?:indinavir_does_not_inhibit_cyp2b6	?:evidence_1096
?:indinavir_does_not_inhibit_cyp2c9	?:evidence_1533
?:indinavir_does_not_inhibit_cyp2e1	?:evidence_1871
?:indinavir_inhibits_cyp3a4	?:evidence_1176
?:indinavir_inhibits_cyp3a4	?:evidence_1821
?:indinavir_inhibits_cyp3a4	?:evidence_1943
?:indinavir_inhibits_cyp3a5	?:evidence_1355
?:indomethacin_bioavailability_continuous_value	?:evidence_1718
?:indomethacin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1357
?:itraconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1877
?:itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1334
?:itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a5	?:evidence_1995
?:itraconazole_increases_auc_3alpha-hydroxypravastatin	?:evidence_1022
?:itraconazole_increases_auc_alprazolam	?:evidence_1400
?:itraconazole_increases_auc_atorvastatin	?:evidence_1387
?:itraconazole_increases_auc_beta-hydroxy-lovastatin	?:evidence_1669
?:itraconazole_increases_auc_lovastatin	?:evidence_1558
?:itraconazole_increases_auc_midazolam	?:evidence_1578
?:itraconazole_increases_auc_pravastatin	?:evidence_1698
?:itraconazole_increases_auc_rosuvastatin	?:evidence_1142
?:itraconazole_increases_auc_triazolam	?:evidence_1002
?:itraconazole_increases_auc_triazolam	?:evidence_1389
?:itraconazole_increases_auc_zolpidem	?:evidence_1792
?:itraconazole_inhibition_constant_cyp3a4	?:evidence_1490
?:itraconazole_inhibits_cyp3a4	?:evidence_1554
?:ketoconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1987
?:ketoconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1113
?:ketoconazole_increases_auc_O-desmethylvenlafaxine	?:evidence_1012
?:ketoconazole_increases_auc_alprazolam	?:evidence_1534
?:ketoconazole_increases_auc_alprazolam	?:evidence_1990
?:ketoconazole_increases_auc_amitriptyline	?:evidence_1056
?:ketoconazole_increases_auc_desvenlafaxine	?:evidence_1512
?:ketoconazole_increases_auc_imipramine	?:evidence_1841
?:ketoconazole_increases_auc_midazolam	?:evidence_1226
?:ketoconazole_increases_auc_simvastatin	?:evidence_1424
?:ketoconazole_increases_auc_triazolam	?:evidence_1537
?:ketoconazole_increases_auc_triazolam	?:evidence_1565
?:ketoconazole_increases_auc_venlafaxine	?:evidence_1046
?:ketoconazole_increases_auc_zolpidem	?:evidence_1708
?:ketoconazole_inhibition_constant_cyp3a4	?:evidence_1171
?:ketoconazole_inhibits_cyp3a4	?:evidence_1369
?:ketoconazole_inhibits_cyp3a4	?:evidence_1414
?:ketoconazole_inhibits_cyp3a4	?:evidence_1688
?:ketoconazole_inhibits_cyp3a4	?:evidence_1732
?:ketoconazole_maximum_concentration_continuous_value	?:evidence_1697
?:ketoconazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1139
?:ketoconazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1232
?:lansoprazole_bioavailability_continuous_value	?:evidence_1616
?:lansoprazole_does_not_inhibit_cyp2d6	?:evidence_1396
?:lansoprazole_does_not_inhibit_cyp3a4	?:evidence_1865
?:lansoprazole_increases_auc_lansoprazole	?:evidence_1788
?:lansoprazole_maximum_concentration_continuous_value	?:evidence_1890
?:lansoprazole_primary_total_clearance_enzyme_cyp2c19	?:evidence_1393
?:lansoprazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1240
?:lansoprazole_substrate_of_cyp2c19	?:evidence_1708
?:lansoprazole_substrate_of_cyp3a4	?:evidence_1462
?:lansoprazole_substrate_of_cyp3a5	?:evidence_1278
?:leflunomide_has_metabolite_teriflunomide	?:evidence_1447
?:lovastatin_bioavailability_continuous_value	?:evidence_1063
?:lovastatin_first_pass_effect_continuous_value	?:evidence_1113
?:lovastatin_has_metabolite_beta-hydroxy-lovastatin	?:evidence_1715
?:lovastatin_inhibition_constant_cyp2c8	?:evidence_1285
?:lovastatin_maximum_concentration_continuous_value	?:evidence_1253
?:lovastatin_primary_total_clearance_enzyme_cyp3a4	?:evidence_1041
?:lovastatin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1691
?:lovastatin_substrate_of_cyp3a4	?:evidence_1117
?:lovastatin_substrate_of_cyp3a4	?:evidence_1476
?:mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c19	?:evidence_1434
?:metronidazole_maximum_concentration_continuous_value	?:evidence_1325
?:metronidazole_maximum_concentration_continuous_value	?:evidence_1417
?:metronidazole_maximum_concentration_continuous_value	?:evidence_1678
?:mexiletine_inhibits_cyp1a2	?:evidence_1357
?:mexiletine_inhibits_cyp1a2	?:evidence_1649
?:mexiletine_inhibits_cyp1a2	?:evidence_1773
?:midazolam_has_metabolite_1'-hydroxymidazolam	?:evidence_1199
?:midazolam_has_metabolite_4-hydroxymidazolam	?:evidence_1067
?:midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4	?:evidence_1113
?:midazolam_primary_total_clearance_enzyme_cyp3a4	?:evidence_1942
?:midazolam_substrate_of_cyp3a5	?:evidence_1530
?:midodrine_bioavailability_continuous_value	?:evidence_1393
?:midodrine_has_metabolite_desglymidodrine	?:evidence_1588
?:mirtazapine_bioavailability_continuous_value	?:evidence_1358
?:mirtazapine_does_not_inhibit_cyp1a2	?:evidence_1171
?:mirtazapine_does_not_inhibit_cyp2c19	?:evidence_1711
?:mirtazapine_does_not_inhibit_cyp2c9	?:evidence_1097
?:mirtazapine_does_not_inhibit_cyp2d6	?:evidence_1947
?:mirtazapine_does_not_inhibit_cyp2e1	?:evidence_1622
?:mirtazapine_fraction_absorbed_continuous_value	?:evidence_1998
?:mirtazapine_is_not_substrate_of_cyp2a6	?:evidence_1673
?:mirtazapine_is_not_substrate_of_cyp2b6	?:evidence_1102
?:mirtazapine_is_not_substrate_of_cyp2c19	?:evidence_1666
?:mirtazapine_is_not_substrate_of_cyp2e1	?:evidence_1491
?:mirtazapine_substrate_of_cyp1a2	?:evidence_1021
?:mirtazapine_substrate_of_cyp1a2	?:evidence_1256
?:mirtazapine_substrate_of_cyp2d6	?:evidence_1770
?:mirtazapine_substrate_of_cyp2d6	?:evidence_1982
?:mirtazapine_substrate_of_cyp3a4	?:evidence_1222
?:mirtazapine_substrate_of_cyp3a4	?:evidence_1412
?:mirtazapine_substrate_of_cyp3a5	?:evidence_1778
?:modafinil-sulfone_inhibits_cyp2c19	?:evidence_1283
?:modafinil_has_metabolite_modafinil-sulfone	?:evidence_1043
?:modafinil_inhibits_cyp2c19	?:evidence_1729
?:modafinil_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1162
?:modafinil_substrate_of_cyp3a4	?:evidence_1038
?:molindone_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1427
?:montelukast_does_not_inhibit_cyp1a2	?:evidence_1373
?:montelukast_does_not_inhibit_cyp1a2	?:evidence_1612
?:montelukast_does_not_inhibit_cyp2a6	?:evidence_1200
?:montelukast_does_not_inhibit_cyp2c19	?:evidence_1038
?:montelukast_does_not_inhibit_cyp2c8	?:evidence_1472
?:montelukast_does_not_inhibit_cyp2c9	?:evidence_1361
?:montelukast_does_not_inhibit_cyp2c9	?:evidence_1804
?:montelukast_does_not_inhibit_cyp2d6	?:evidence_1665
?:montelukast_does_not_inhibit_cyp3a4	?:evidence_1944
?:montelukast_inhibition_constant_cyp2c8	?:evidence_1397
?:nefazodone_does_not_inhibit_cyp1a2	?:evidence_1034
?:nefazodone_in_viVo_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1462
?:nefazodone_increases_auc_alprazolam	?:evidence_1127
?:nefazodone_increases_auc_alprazolam	?:evidence_1585
?:nefazodone_increases_auc_alprazolam	?:evidence_1772
?:nefazodone_increases_auc_midazolam	?:evidence_1324
?:nefazodone_increases_auc_triazolam	?:evidence_1234
?:nefazodone_increases_auc_triazolam	?:evidence_1265
?:nefazodone_inhibits_cyp3a4	?:evidence_1134
?:nefazodone_inhibits_cyp3a4	?:evidence_1510
?:nefazodone_inhibits_cyp3a4	?:evidence_1659
?:nefazodone_inhibits_cyp3a5	?:evidence_1427
?:nefazodone_is_not_substrate_of_cyp1a2	?:evidence_1095
?:nefazodone_is_not_substrate_of_cyp2c19	?:evidence_1490
?:nefazodone_is_not_substrate_of_cyp2c8	?:evidence_1052
?:nefazodone_is_not_substrate_of_cyp2c9	?:evidence_1983
?:nefazodone_is_not_substrate_of_cyp2d6	?:evidence_1295
?:nefazodone_is_not_substrate_of_cyp2d6	?:evidence_1576
?:nefazodone_substrate_of_cyp3a4	?:evidence_1544
?:nicardipine_bioavailability_continuous_value	?:evidence_1911
?:norfloxacin_inhibits_cyp1a2	?:evidence_1066
?:norfluoxetine_inhibition_constant_cyp3a4	?:evidence_1138
?:olanzapine_has_metabolite_10-N-glucuronide	?:evidence_1245
?:olanzapine_inhibition_constant_cyp2c19	?:evidence_1237
?:olanzapine_inhibition_constant_cyp2c9	?:evidence_1907
?:olanzapine_inhibition_constant_cyp3a4	?:evidence_1114
?:olanzapine_maximum_concentration_continuous_value	?:evidence_1050
?:olanzapine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1244
?:olanzapine_substrate_of_cyp2d6	?:evidence_1066
?:omeprazole_does_not_inhibit_cyp2d6	?:evidence_1040
?:omeprazole_in_vitro_probe_substrate_of_enzyme_cyp2c19	?:evidence_1374
?:omeprazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c19	?:evidence_1815
?:omeprazole_increases_auc_escitalopram	?:evidence_1768
?:omeprazole_inhibits_cyp2c19	?:evidence_1968
?:omeprazole_primary_total_clearance_enzyme_cyp2c19	?:evidence_1887
?:p-nitrophenol_in_vitro_probe_substrate_of_enzyme_cyp2e1	?:evidence_1719
?:paclitaxel_has_metabolite_6alpha-hydroxy-paclitaxel	?:evidence_1470
?:paclitaxel_in_vitro_probe_substrate_of_enzyme_cyp2c8	?:evidence_1884
?:paliperidone_bioavailability_continuous_value	?:evidence_1771
?:paliperidone_does_not_inhibit_cyp1a2	?:evidence_1348
?:paliperidone_does_not_inhibit_cyp1a2	?:evidence_1464
?:paliperidone_does_not_inhibit_cyp2a6	?:evidence_1247
?:paliperidone_does_not_inhibit_cyp2a6	?:evidence_1582
?:paliperidone_does_not_inhibit_cyp2c19	?:evidence_1657
?:paliperidone_does_not_inhibit_cyp2c8	?:evidence_1764
?:paliperidone_does_not_inhibit_cyp2c9	?:evidence_1198
?:paliperidone_does_not_inhibit_cyp2c9	?:evidence_1726
?:paliperidone_does_not_inhibit_cyp2d6	?:evidence_1787
?:paliperidone_does_not_inhibit_cyp2e1	?:evidence_1594
?:paliperidone_does_not_inhibit_cyp3a4	?:evidence_1075
?:paliperidone_does_not_inhibit_cyp3a5	?:evidence_1031
?:paliperidone_inhibition_constant_cyp2d6	?:evidence_1778
?:paliperidone_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1648
?:pantoprazole_bioavailability_continuous_value	?:evidence_1896
?:pantoprazole_does_not_inhibit_cyp2d6	?:evidence_1406
?:pantoprazole_maximum_concentration_continuous_value	?:evidence_1525
?:pantoprazole_primary_total_clearance_enzyme_cyp2c19	?:evidence_1460
?:pantoprazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1869
?:pantoprazole_substrate_of_cyp2c19	?:evidence_1410
?:pantoprazole_substrate_of_cyp3a4	?:evidence_1470
?:paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6	?:evidence_1395
?:paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6	?:evidence_1507
?:paroxetine_increases_auc_desipramine	?:evidence_1222
?:paroxetine_increases_auc_desipramine	?:evidence_1329
?:paroxetine_increases_auc_desipramine	?:evidence_1638
?:paroxetine_increases_auc_duloxetine	?:evidence_1235
?:paroxetine_increases_auc_duloxetine	?:evidence_1841
?:paroxetine_increases_auc_imipramine	?:evidence_1993
?:paroxetine_increases_auc_mirtazapine	?:evidence_1906
?:paroxetine_increases_auc_nortriptyline	?:evidence_1658
?:paroxetine_increases_auc_paliperidone	?:evidence_1036
?:paroxetine_increases_auc_risperidone	?:evidence_1517
?:paroxetine_inhibits_cyp2d6	?:evidence_1005
?:paroxetine_inhibits_cyp2d6	?:evidence_1120
?:paroxetine_inhibits_cyp2d6	?:evidence_1389
?:paroxetine_inhibits_cyp2d6	?:evidence_1462
?:paroxetine_inhibits_cyp2d6	?:evidence_1787
?:paroxetine_permanently_deactivates_catalytic_function_cyp2d6	?:evidence_1466
?:paroxetine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1902
?:paroxetine_substrate_of_cyp2d6	?:evidence_1623
?:perphenazine_does_not_inhibit_cyp2c19	?:evidence_1074
?:perphenazine_has_metabolite_7-hydroxyperphenazine	?:evidence_1433
?:perphenazine_inhibition_constant_cyp1a2	?:evidence_1062
?:perphenazine_inhibition_constant_cyp2d6	?:evidence_1527
?:perphenazine_maximum_concentration_continuous_value	?:evidence_1117
?:perphenazine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1362
?:perphenazine_substrate_of_cyp1a2	?:evidence_1193
?:perphenazine_substrate_of_cyp1a2	?:evidence_1232
?:perphenazine_substrate_of_cyp2c19	?:evidence_1291
?:perphenazine_substrate_of_cyp2d6	?:evidence_1080
?:perphenazine_substrate_of_cyp2d6	?:evidence_1358
?:perphenazine_substrate_of_cyp2d6	?:evidence_1713
?:perphenazine_substrate_of_cyp2d6	?:evidence_1898
?:perphenazine_substrate_of_cyp2d6	?:evidence_1998
?:perphenazine_substrate_of_cyp3a4	?:evidence_1446
?:perphenazine_substrate_of_cyp3a4	?:evidence_1832
?:phenacetin_in_vitro_probe_substrate_of_enzyme_cyp1a2	?:evidence_1658
?:pioglitazone_inhibition_constant_cyp2c8	?:evidence_1274
?:prasugrel_increases_auc_bupropion	?:evidence_1681
?:pravastatin_does_not_inhibit_cyp2c8	?:evidence_1375
?:pravastatin_has_metabolite_3alpha-hydroxypravastatin	?:evidence_1300
?:pravastatin_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1101
?:propafenone_inhibits_cyp1a2	?:evidence_1005
?:propoxyphene_has_metabolite_norpropoxyphene	?:evidence_1364
?:quetiapine_does_not_inhibit_cyp1a2	?:evidence_1336
?:quetiapine_does_not_inhibit_cyp2c19	?:evidence_1214
?:quetiapine_does_not_inhibit_cyp2c9	?:evidence_1916
?:quetiapine_does_not_inhibit_cyp2d6	?:evidence_1485
?:quetiapine_does_not_inhibit_cyp3a4	?:evidence_1344
?:quetiapine_has_metabolite_7-hydroxy-N-desalkyl-quetiapine	?:evidence_1341
?:quetiapine_has_metabolite_7-hydroxy-quetiapine	?:evidence_1352
?:quetiapine_has_metabolite_N-desalkylquetiapine	?:evidence_1020
?:quetiapine_has_metabolite_quetiapine-sulfoxide	?:evidence_1620
?:quetiapine_is_not_substrate_of_cyp1a2	?:evidence_1880
?:quetiapine_is_not_substrate_of_cyp2c19	?:evidence_1296
?:quetiapine_is_not_substrate_of_cyp2c9	?:evidence_1529
?:quetiapine_is_not_substrate_of_cyp2e1	?:evidence_1579
?:quetiapine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1559
?:quetiapine_substrate_of_cyp3a4	?:evidence_1019
?:quetiapine_substrate_of_cyp3a4	?:evidence_1706
?:quetiapine_substrate_of_cyp3a4	?:evidence_1897
?:quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6	?:evidence_1683
?:quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6	?:evidence_1584
?:quinidine_increases_auc_venlafaxine	?:evidence_1638
?:quinidine_inhibits_cyp2d6	?:evidence_1746
?:rabeprazole_bioavailability_continuous_value	?:evidence_1600
?:rabeprazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1909
?:rabeprazole_substrate_of_cyp2c19	?:evidence_1126
?:rabeprazole_substrate_of_cyp3a4	?:evidence_1038
?:rabeprazole_substrate_of_cyp3a4	?:evidence_1166
?:rabeprazole_substrate_of_cyp3a5	?:evidence_1685
?:ranolazine_inhibits_cyp2d6	?:evidence_1690
?:ranolazine_inhibits_cyp3a4	?:evidence_1930
?:ranolazine_inhibits_cyp3a5	?:evidence_1436
?:ranolazine_maximum_concentration_continuous_value	?:evidence_1840
?:ranolazine_primary_total_clearance_enzyme_cyp3a4	?:evidence_1663
?:ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1503
?:ranolazine_substrate_of_cyp2d6	?:evidence_1405
?:reduced-haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine	?:evidence_1472
?:reduced-haloperidol_substrate_of_cyp3a4	?:evidence_1777
?:reduced-haloperidol_substrate_of_cyp3a4	?:evidence_1891
?:risperidone_bioavailability_continuous_value	?:evidence_1472
?:risperidone_bioavailability_continuous_value	?:evidence_1560
?:risperidone_does_not_inhibit_cyp2c19	?:evidence_1593
?:risperidone_has_metabolite_9-hydroxyrisperidone	?:evidence_1234
?:risperidone_has_metabolite_9-hydroxyrisperidone	?:evidence_1760
?:risperidone_inhibition_constant_cyp2d6	?:evidence_1817
?:risperidone_inhibition_constant_cyp2d6	?:evidence_1959
?:risperidone_maximum_concentration_continuous_value	?:evidence_1431
?:risperidone_primary_metabolic_clearance_enzyme_cyp2d6	?:evidence_1272
?:risperidone_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1769
?:risperidone_substrate_of_cyp2d6	?:evidence_1579
?:risperidone_substrate_of_cyp2d6	?:evidence_1931
?:risperidone_substrate_of_cyp3a4	?:evidence_1198
?:ritonavir_increases_auc_trazodone	?:evidence_1745
?:ritonavir_inhibits_cyp2d6	?:evidence_1116
?:ritonavir_inhibits_cyp2d6	?:evidence_1910
?:ritonavir_inhibits_cyp3a4	?:evidence_1008
?:ritonavir_inhibits_cyp3a4	?:evidence_1614
?:ritonavir_inhibits_cyp3a4	?:evidence_1796
?:ritonavir_inhibits_cyp3a5	?:evidence_1909
?:rosiglitazone_does_not_inhibit_cyp1a1	?:evidence_1951
?:rosiglitazone_does_not_inhibit_cyp1a2	?:evidence_1653
?:rosiglitazone_does_not_inhibit_cyp2a6	?:evidence_1564
?:rosiglitazone_does_not_inhibit_cyp2b6	?:evidence_1396
?:rosiglitazone_does_not_inhibit_cyp2c19	?:evidence_1202
?:rosiglitazone_does_not_inhibit_cyp2c8	?:evidence_1526
?:rosiglitazone_does_not_inhibit_cyp2c9	?:evidence_1643
?:rosiglitazone_does_not_inhibit_cyp2d6	?:evidence_1277
?:rosiglitazone_does_not_inhibit_cyp2e1	?:evidence_1841
?:rosiglitazone_does_not_inhibit_cyp3a4	?:evidence_1752
?:rosiglitazone_does_not_inhibit_cyp3a5	?:evidence_1845
?:rosiglitazone_inhibition_constant_cyp2c8	?:evidence_1385
?:rosiglitazone_primary_total_clearance_enzyme_cyp2c8	?:evidence_1201
?:rosuvastatin_bioavailability_continuous_value	?:evidence_1507
?:rosuvastatin_bioavailability_continuous_value	?:evidence_1861
?:rosuvastatin_does_not_inhibit_cyp2c8	?:evidence_1757
?:rosuvastatin_fraction_absorbed_continuous_value	?:evidence_1734
?:rosuvastatin_has_metabolite_N-desmethylrosuvastatin	?:evidence_1553
?:rosuvastatin_is_not_substrate_of_cyp3a4	?:evidence_1519
?:rosuvastatin_maximum_concentration_continuous_value	?:evidence_1713
?:rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c9	?:evidence_1222
?:rosuvastatin_primary_total_clearance_mechanism_Biliary_Excretion	?:evidence_1065
?:sertraline_has_metabolite_N-desmethylsertraline	?:evidence_1433
?:sertraline_increases_auc_desipramine	?:evidence_1451
?:sertraline_increases_auc_desipramine	?:evidence_1790
?:sertraline_increases_auc_desipramine	?:evidence_1938
?:sertraline_inhibits_cyp2d6	?:evidence_1197
?:sertraline_inhibits_cyp2d6	?:evidence_1210
?:sertraline_inhibits_cyp2d6	?:evidence_1797
?:sertraline_substrate_of_cyp2c19	?:evidence_1337
?:sildenafil_primary_total_clearance_enzyme_cyp3a4	?:evidence_1839
?:simvastatin_does_not_inhibit_cyp3a4	?:evidence_1448
?:simvastatin_has_metabolite_beta-hydroxy-simvastatin	?:evidence_1600
?:simvastatin_inhibition_constant_cyp2c8	?:evidence_1743
?:simvastatin_primary_total_clearance_enzyme_cyp3a4	?:evidence_1931
?:simvastatin_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1633
?:simvastatin_substrate_of_cyp3a4	?:evidence_1111
?:simvastatin_substrate_of_cyp3a4	?:evidence_1853
?:simvastatin_substrate_of_cyp3a4	?:evidence_1859
?:sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c9	?:evidence_1310
?:sulphaphenazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c9	?:evidence_1560
?:tamoxifen_has_metabolite_4-hydroxytamoxifin	?:evidence_1228
?:tamoxifen_has_metabolite_N-desmethyltamoxifen	?:evidence_1461
?:tamoxifen_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1862
?:tamoxifen_substrate_of_cyp2c9	?:evidence_1537
?:tamoxifen_substrate_of_cyp2d6	?:evidence_1224
?:tamoxifen_substrate_of_cyp3a4	?:evidence_1339
?:tamoxifen_substrate_of_cyp3a5	?:evidence_1605
?:telithromycin_inhibits_cyp3a4	?:evidence_1164
?:telithromycin_inhibits_cyp3a4	?:evidence_1465
?:telithromycin_inhibits_cyp3a4	?:evidence_1913
?:telithromycin_inhibits_cyp3a5	?:evidence_1827
?:terbinafine_increases_auc_paroxetine	?:evidence_1720
?:terbinafine_increases_auc_venlafaxine	?:evidence_1477
?:terbinafine_inhibits_cyp2d6	?:evidence_1372
?:terbinafine_inhibits_cyp2d6	?:evidence_1471
?:teriflunomide_inhibits_cyp2c9	?:evidence_1336
?:testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a4	?:evidence_1911
?:theophylline_has_metabolite_1,3-dimethyluric-acid	?:evidence_1178
?:theophylline_has_metabolite_1-methylxanthine	?:evidence_1604
?:theophylline_has_metabolite_3-methylxanthine	?:evidence_1819
?:theophylline_has_metabolite_caffeine	?:evidence_1876
?:theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a2	?:evidence_1007
?:theophylline_primary_total_clearance_enzyme_cyp1a2	?:evidence_1105
?:theophylline_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1060
?:thioridazine_does_not_inhibit_cyp2c19	?:evidence_1284
?:thioridazine_has_metabolite_mesoridazine	?:evidence_1012
?:thioridazine_has_metabolite_mesoridazine	?:evidence_1467
?:thioridazine_has_metabolite_sulforidazine	?:evidence_1778
?:thioridazine_has_metabolite_thioridazine-5-sulfoxide	?:evidence_1919
?:thioridazine_inhibition_constant_cyp2d6	?:evidence_1047
?:thioridazine_primary_total_clearance_enzyme_cyp2d6	?:evidence_1076
?:thioridazine_substrate_of_cyp2d6	?:evidence_1345
?:thioridazine_substrate_of_cyp2d6	?:evidence_1682
?:thiothixene_does_not_inhibit_cyp2c19	?:evidence_1150
?:thiothixene_inhibition_constant_cyp2d6	?:evidence_1121
?:threohydrobupropion_maximum_concentration_continuous_value	?:evidence_1972
?:threohydrobupropion_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1637
?:ticlopidine_increases_auc_bupropion	?:evidence_1435
?:ticlopidine_inhibition_constant_cyp2b6	?:evidence_1544
?:ticlopidine_inhibition_constant_cyp2c19	?:evidence_1369
?:tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c9	?:evidence_1304
?:tolbutamide_primary_total_clearance_enzyme_cyp2c9	?:evidence_1318
?:topiramate_does_not_inhibit_cyp1a2	?:evidence_1340
?:topiramate_does_not_inhibit_cyp1a2	?:evidence_1597
?:topiramate_does_not_inhibit_cyp2a6	?:evidence_1014
?:topiramate_does_not_inhibit_cyp2a6	?:evidence_1288
?:topiramate_does_not_inhibit_cyp2b6	?:evidence_1106
?:topiramate_does_not_inhibit_cyp2c19	?:evidence_1562
?:topiramate_does_not_inhibit_cyp2c9	?:evidence_1142
?:topiramate_does_not_inhibit_cyp2c9	?:evidence_1708
?:topiramate_does_not_inhibit_cyp2d6	?:evidence_1641
?:topiramate_does_not_inhibit_cyp2e1	?:evidence_1102
?:topiramate_does_not_inhibit_cyp2e1	?:evidence_1377
?:topiramate_does_not_inhibit_cyp3a4	?:evidence_1062
?:topiramate_does_not_inhibit_cyp3a4	?:evidence_1193
?:topiramate_does_not_inhibit_cyp3a5	?:evidence_1771
?:topiramate_primary_total_clearance_mechanism_Renal_Excretion	?:evidence_1732
?:trazodone_bioavailability_continuous_value	?:evidence_1403
?:trazodone_bioavailability_continuous_value	?:evidence_1725
?:trazodone_has_metabolite_M-chlorophenylpiperazine	?:evidence_1553
?:trazodone_maximum_concentration_continuous_value	?:evidence_1607
?:trazodone_substrate_of_cyp3a4	?:evidence_1657
?:triazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4	?:evidence_1785
?:triazolam_primary_total_clearance_enzyme_cyp3a4	?:evidence_1520
?:trimethoprim_inhibits_cyp2c8	?:evidence_1353
?:troleandomycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a4	?:evidence_1465
?:valproate_increases_auc_hydroxybupropion	?:evidence_1806
?:valproate_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1252
?:venlafaxine_does_not_inhibit_cyp1a2	?:evidence_1124
?:venlafaxine_does_not_inhibit_cyp1a2	?:evidence_1381
?:venlafaxine_does_not_inhibit_cyp1a2	?:evidence_1623
?:venlafaxine_does_not_inhibit_cyp2c9	?:evidence_1345
?:venlafaxine_does_not_inhibit_cyp2c9	?:evidence_1735
?:venlafaxine_does_not_inhibit_cyp3a4	?:evidence_1022
?:venlafaxine_does_not_inhibit_cyp3a4	?:evidence_1365
?:venlafaxine_fraction_absorbed_continuous_value	?:evidence_1493
?:venlafaxine_has_metabolite_N-desmethylvenlafaxine	?:evidence_1586
?:venlafaxine_has_metabolite_N-desmethylvenlafaxine	?:evidence_1695
?:venlafaxine_has_metabolite_O-desmethylvenlafaxine	?:evidence_1327
?:venlafaxine_has_metabolite_O-desmethylvenlafaxine	?:evidence_1510
?:venlafaxine_has_metabolite_O-desmethylvenlafaxine	?:evidence_1909
?:venlafaxine_increases_auc_desipramine	?:evidence_1262
?:venlafaxine_increases_auc_haloperidol	?:evidence_1676
?:venlafaxine_increases_auc_imipramine	?:evidence_1827
?:venlafaxine_increases_auc_risperidone	?:evidence_1143
?:venlafaxine_inhibits_cyp2d6	?:evidence_1308
?:venlafaxine_maximum_concentration_continuous_value	?:evidence_1355
?:venlafaxine_maximum_concentration_continuous_value	?:evidence_1961
?:venlafaxine_maximum_concentration_continuous_value	?:evidence_1965
?:venlafaxine_primary_total_clearance_enzyme_cyp2d6	?:evidence_1840
?:venlafaxine_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1314
?:venlafaxine_substrate_of_cyp2d6	?:evidence_1078
?:venlafaxine_substrate_of_cyp2d6	?:evidence_1557
?:venlafaxine_substrate_of_cyp2d6	?:evidence_1742
?:venlafaxine_substrate_of_cyp3a4	?:evidence_1853
?:verapamil_increases_auc_imipramine	?:evidence_1061
?:verapamil_increases_auc_risperidone	?:evidence_1430
?:verapamil_inhibits_cyp1a2	?:evidence_1819
?:verapamil_inhibits_cyp3a4	?:evidence_1543
?:verapamil_inhibits_cyp3a5	?:evidence_1094
?:voriconazole-N-oxide_inhibits_cyp2c19	?:evidence_1850
?:voriconazole-N-oxide_inhibits_cyp2c9	?:evidence_1690
?:voriconazole-N-oxide_inhibits_cyp3a4	?:evidence_1948
?:voriconazole_bioavailability_continuous_value	?:evidence_1020
?:voriconazole_has_metabolite_voriconazole-N-oxide	?:evidence_1292
?:voriconazole_inhibits_cyp2c19	?:evidence_1769
?:voriconazole_inhibits_cyp2c9	?:evidence_1364
?:voriconazole_inhibits_cyp3a4	?:evidence_1156
?:voriconazole_maximum_concentration_continuous_value	?:evidence_1214
?:voriconazole_maximum_concentration_continuous_value	?:evidence_1360
?:voriconazole_primary_total_clearance_enzyme_cyp2c19	?:evidence_1198
?:voriconazole_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1698
?:voriconazole_substrate_of_cyp2c19	?:evidence_1647
?:voriconazole_substrate_of_cyp2c9	?:evidence_1224
?:voriconazole_substrate_of_cyp3a4	?:evidence_1237
?:warfarin_primary_total_clearance_enzyme_cyp2c9	?:evidence_1053
?:zafirlukast_inhibits_cyp2c9	?:evidence_1366
?:zafirlukast_inhibits_cyp2c9	?:evidence_1896
?:zafirlukast_inhibits_cyp3a4	?:evidence_1135
?:zafirlukast_maximum_concentration_continuous_value	?:evidence_1739
?:zafirlukast_substrate_of_cyp2c9	?:evidence_1062
?:zaleplon_bioavailability_continuous_value	?:evidence_1513
?:zaleplon_is_not_substrate_of_cyp2d6	?:evidence_1376
?:zaleplon_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1775
?:zaleplon_substrate_of_cyp3a4	?:evidence_1038
?:ziprasidone_does_not_inhibit_cyp1a2	?:evidence_1871
?:ziprasidone_does_not_inhibit_cyp1a2	?:evidence_1890
?:ziprasidone_does_not_inhibit_cyp2c19	?:evidence_1895
?:ziprasidone_does_not_inhibit_cyp2c19	?:evidence_1941
?:ziprasidone_does_not_inhibit_cyp2c9	?:evidence_1517
?:ziprasidone_does_not_inhibit_cyp2c9	?:evidence_1772
?:ziprasidone_does_not_inhibit_cyp2d6	?:evidence_1261
?:ziprasidone_does_not_inhibit_cyp2d6	?:evidence_1989
?:ziprasidone_does_not_inhibit_cyp3a4	?:evidence_1476
?:ziprasidone_has_metabolite_S-methyl-dihydroziprasidone	?:evidence_1000
?:ziprasidone_has_metabolite_benzisothiazole-sulphone	?:evidence_1045
?:ziprasidone_has_metabolite_benzisothiazole-sulphoxide	?:evidence_1782
?:ziprasidone_has_metabolite_ziprasidone-sulphoxide	?:evidence_1115
?:ziprasidone_has_metabolite_ziprasidone-sulphoxide	?:evidence_1688
?:ziprasidone_inhibition_constant_cyp2d6	?:evidence_1177
?:ziprasidone_is_not_substrate_of_cyp1a2	?:evidence_1880
?:ziprasidone_is_not_substrate_of_cyp1a2	?:evidence_1884
?:ziprasidone_is_not_substrate_of_cyp2c19	?:evidence_1693
?:ziprasidone_is_not_substrate_of_cyp2c9	?:evidence_1874
?:ziprasidone_is_not_substrate_of_cyp2d6	?:evidence_1080
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1035
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1099
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1235
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1547
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1570
?:ziprasidone_maximum_concentration_continuous_value	?:evidence_1952
?:ziprasidone_primary_total_clearance_mechanism_Metabolic_Clearance	?:evidence_1755
?:ziprasidone_substrate_of_cyp1a2	?:evidence_1942
?:ziprasidone_substrate_of_cyp3a4	?:evidence_1064
?:ziprasidone_substrate_of_cyp3a4	?:evidence_1245
?:ziprasidone_substrate_of_cyp3a4	?:evidence_1613
?:ziprasidone_substrate_of_cyp3a4	?:evidence_1764
?:zolpidem_maximum_concentration_continuous_value	?:evidence_1754
?:zolpidem_substrate_of_cyp3a4	?:evidence_1274
?:zolpidem_substrate_of_cyp3a4	?:evidence_1782
?:zolpidem_substrate_of_cyp3a5	?:evidence_1812